Leila Rahbarnia

11PUBLICATIONS
11CO-AUTHORS
Molecular targetsMedical devicesPharmaceutical delivery technologiesBiomolecular modelling and designGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 23, 2026
Computational Design Of A Peptide Candidate Targeting NOTCH1 And PI3K/AKT Signaling Pathways In Cancer: A Coarse-Grained Molecular Dynamics Simulation Study.

|Jul 20, 2026
In Silico Design and Structural Characterization of 4D5mocB-PE24: A Novel Immunotoxin for EpCAM-Targeted Cancer Therapy.

|Jun 01, 2024
Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update.

Samaneh Jahandar-Lashaki, Safar Farajnia, Aref Faraji-Barhagh

|Mar 29, 2023
The Synthetic Antimicrobial Peptide Derived From Melittin Displays Low Toxicity and Anti-infectious Properties.

Parisa Mansouri Rad, Leila Rahbarnia, Azam Safary

|Jun 10, 2022
Bio-nano scale modifications of melittin for improving therapeutic efficacy.

Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Amir-Hossein Olfati

|Dec 13, 2021
Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection.

Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Leila Rahbarnia

Pageof 2

Frequent Collaborators

4 joint publications

Azam Safary

2 joint publications

Safar Farajnia

1 joint publications

Safar Farajnia

1 joint publications

Mostafa Akbarzadeh-Khiavi